WallStreetZenWallStreetZen

NASDAQ: NTLA
Intellia Therapeutics Inc Stock Forecast, Predictions & Price Target

Analyst price target for NTLA

Based on 8 analysts offering 12 month price targets for Intellia Therapeutics Inc.
Min Forecast
$32.00-2.02%
Avg Forecast
$64.25+96.72%
Max Forecast
$85.00+160.26%

Should I buy or sell NTLA stock?

Based on 8 analysts offering ratings for Intellia Therapeutics Inc.
Strong Buy
Strong Buy
3 analysts 37.5%
Buy
4 analysts 50%
Hold
1 analysts 12.5%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%

Be the first to know when Wall Street analysts revise their NTLA stock forecasts and price targets.

NTLA stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2024-02-23
lockedlocked$00.00+00.00%2024-02-23
lockedlocked$00.00+00.00%2023-11-13
lockedlocked$00.00+00.00%2023-11-13
lockedlocked$00.00+00.00%2023-11-10
RBC Capital
Bottom 6%
6
BuyMaintains$70.00+114.33%2023-11-10
Raymond James
Top 7%
94
BuyMaintains$57.00+74.53%2023-11-10
Cantor Fitzgerald
Bottom 7%
7
Strong BuyReiterates$65.00+99.02%2023-09-13

1 of 1

Forecast return on equity

Is NTLA forecast to generate an efficient return?
Company
N/A
Industry
N/A
Market
35.11%

Forecast return on assets

Is NTLA forecast to generate an efficient return on assets?
Company
N/A
Industry
N/A

NTLA revenue forecast

What is NTLA's revenue in the next 3 years based on estimates from 13 analysts?
Avg 1 year Forecast
$51.8M+42.73%
Avg 2 year Forecast
$75.0M+106.82%
Avg 3 year Forecast
$127.5M+251.52%
NTLA's revenue is forecast to... subscribe to Premium to read more.
Forecast High Revenue Growth Forecast

NTLA revenue growth forecast

How is NTLA forecast to perform vs Biotechnology companies and vs the US market?
Company
48.79%
Industry
45.89%
Market
10.82%
NTLA's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
NTLA's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

NTLA vs Biotech Stocks

TickerPricePrice TargetUp/downsideConsensus
NTLA$32.66$64.25+96.72%Strong Buy
IBRX$4.71N/AN/A
CRNX$46.03$48.33+5.00%Strong Buy
ARVN$47.30$59.57+25.94%Strong Buy
MLTX$50.92$73.50+44.34%Strong Buy

Intellia Therapeutics Stock Forecast FAQ

Is Intellia Therapeutics Stock a good buy in 2024, according to Wall Street analysts?

The consensus among 8 Wall Street analysts covering (NASDAQ: NTLA) stock is to Strong Buy NTLA stock.

Out of 8 analysts, 3 (37.5%) are recommending NTLA as a Strong Buy, 4 (50%) are recommending NTLA as a Buy, 1 (12.5%) are recommending NTLA as a Hold, 0 (0%) are recommending NTLA as a Sell, and 0 (0%) are recommending NTLA as a Strong Sell.

If you're new to stock investing, here's how to buy Intellia Therapeutics stock.

What is NTLA's revenue growth forecast for 2024-2026?

(NASDAQ: NTLA) Intellia Therapeutics's forecast annual revenue growth rate of 48.79% is forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 45.89%, and it is also forecast to beat the US market's average forecast revenue growth rate of 10.82%.

Intellia Therapeutics's revenue in 2024 is $36,275,000.On average, 13 Wall Street analysts forecast NTLA's revenue for 2024 to be $4,975,813,012, with the lowest NTLA revenue forecast at $1,175,381,333, and the highest NTLA revenue forecast at $9,850,906,513. On average, 11 Wall Street analysts forecast NTLA's revenue for 2025 to be $7,210,190,822, with the lowest NTLA revenue forecast at $864,957,645, and the highest NTLA revenue forecast at $20,182,345,050.

In 2026, NTLA is forecast to generate $12,254,912,127 in revenue, with the lowest revenue forecast at $5,784,644,517 and the highest revenue forecast at $16,904,155,575.

What is NTLA's forecast return on assets (ROA) for 2024-2027?

(NASDAQ: NTLA) forecast ROA is N/A, which is lower than the forecast US Biotechnology industry average of N/A.

What is NTLA's Price Target?

According to 8 Wall Street analysts that have issued a 1 year NTLA price target, the average NTLA price target is $64.25, with the highest NTLA stock price forecast at $85.00 and the lowest NTLA stock price forecast at $32.00.

On average, Wall Street analysts predict that Intellia Therapeutics's share price could reach $64.25 by Feb 23, 2025. The average Intellia Therapeutics stock price prediction forecasts a potential upside of 96.72% from the current NTLA share price of $32.66.

What is NTLA's forecast return on equity (ROE) for 2024-2027?

(NASDAQ: NTLA) forecast ROE is N/A, which is considered weak.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.